Motif Neurotech

Motif Neurotech is pioneering wireless minimally-invasive neuromodulation therapeutics for mental health.

www.motifneuro.tech
Houston, TX

CEO: Jacob Robinson, Ph.D
Arboretum Lead: Tom Shehab, MD

IN THE NEWS
April 27, 2026 in Home Page, Motif Neurotech, News Page

Motif Neurotech Receives FDA Approval to Begin First Clinical Trial of its Therapeutic BCI for Treatment-Resistant Depression

Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for…
Read More
January 24, 2024 in Home Page, Motif Neurotech, News Page

Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression

Motif Neurotech, a neurotechnology company developing minimally-invasive bioelectronics for mental health, announced today an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures, with participation from new investors…
Read More